Cord blood banking industry faces scrutiny over unproven claims and high costs

Out­look to con­duct an­oth­er tri­al for eye drug af­ter re­jec­tion: Out­look Ther­a­peu­tics an­nounced Thurs­day that the FDA wants an ad­di­tion­al study as­sess­ing be­va­cizum­ab in wet

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes